BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 17073604)

  • 1. Transposons for gene therapy!
    Ivics Z; Izsvák Z
    Curr Gene Ther; 2006 Oct; 6(5):593-607. PubMed ID: 17073604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleeping beauty transposition: biology and applications for molecular therapy.
    Izsvák Z; Ivics Z
    Mol Ther; 2004 Feb; 9(2):147-56. PubMed ID: 14759798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of Sleeping Beauty transposons for nonviral gene therapy.
    Liu H; Visner GA
    IUBMB Life; 2007 Jun; 59(6):374-9. PubMed ID: 17613167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleeping beauty transposon-mediated gene therapy for prolonged expression.
    Hackett PB; Ekker SC; Largaespada DA; McIvor RS
    Adv Genet; 2005; 54():189-232. PubMed ID: 16096013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration and long-term expression in xenografted human glioblastoma cells using a plasmid-based transposon system.
    Ohlfest JR; Lobitz PD; Perkinson SG; Largaespada DA
    Mol Ther; 2004 Aug; 10(2):260-8. PubMed ID: 15294173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translating Sleeping Beauty transposition into cellular therapies: victories and challenges.
    Izsvák Z; Hackett PB; Cooper LJ; Ivics Z
    Bioessays; 2010 Sep; 32(9):756-67. PubMed ID: 20652893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroviral vectors and transposons for stable gene therapy: advances, current challenges and perspectives.
    Vargas JE; Chicaybam L; Stein RT; Tanuri A; Delgado-Cañedo A; Bonamino MH
    J Transl Med; 2016 Oct; 14(1):288. PubMed ID: 27729044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Sleeping Beauty transposon system: a non-viral vector for gene therapy.
    Aronovich EL; McIvor RS; Hackett PB
    Hum Mol Genet; 2011 Apr; 20(R1):R14-20. PubMed ID: 21459777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Awakening gene therapy with Sleeping Beauty transposons.
    Essner JJ; McIvor RS; Hackett PB
    Curr Opin Pharmacol; 2005 Oct; 5(5):513-9. PubMed ID: 16084771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of adenovirus hybrid vectors for Sleeping Beauty transposition in large mammals.
    Hausl M; Zhang W; Voigtländer R; Müther N; Rauschhuber C; Ehrhardt A
    Curr Gene Ther; 2011 Oct; 11(5):363-74. PubMed ID: 21888620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates.
    Izsvák Z; Ivics Z; Plasterk RH
    J Mol Biol; 2000 Sep; 302(1):93-102. PubMed ID: 10964563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transposons: Moving Forward from Preclinical Studies to Clinical Trials.
    Tipanee J; VandenDriessche T; Chuah MK
    Hum Gene Ther; 2017 Nov; 28(11):1087-1104. PubMed ID: 28920716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleeping Beauty-baculovirus hybrid vectors for long-term gene expression in the eye.
    Turunen TA; Laakkonen JP; Alasaarela L; Airenne KJ; Ylä-Herttuala S
    J Gene Med; 2014; 16(1-2):40-53. PubMed ID: 24464652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary Transposon Tools: A Review and Guide through Mechanisms and Applications of
    Sandoval-Villegas N; Nurieva W; Amberger M; Ivics Z
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34064900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of CAR-T Cells with Sleeping Beauty Transposon Gene Transfer.
    Prommersberger S; Monjezi R; Botezatu L; Miskey C; Amberger M; Mestermann K; Hudecek M; Ivics Z
    Methods Mol Biol; 2022; 2521():41-66. PubMed ID: 35732992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient stable gene transfer into human cells by the Sleeping Beauty transposon vectors.
    Izsvák Z; Chuah MK; Vandendriessche T; Ivics Z
    Methods; 2009 Nov; 49(3):287-97. PubMed ID: 19615447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helper-Independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo.
    Mikkelsen JG; Yant SR; Meuse L; Huang Z; Xu H; Kay MA
    Mol Ther; 2003 Oct; 8(4):654-65. PubMed ID: 14529839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes simplex virus/Sleeping Beauty vector-based embryonic gene transfer using the HSB5 mutant: loss of apparent transposition hyperactivity in vivo.
    de Silva S; Mastrangelo MA; Lotta LT; Burris CA; Izsvák Z; Ivics Z; Bowers WJ
    Hum Gene Ther; 2010 Nov; 21(11):1603-13. PubMed ID: 20507234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative genomic integration profiling of Sleeping Beauty transposons mobilized with high efficacy from integrase-defective lentiviral vectors in primary human cells.
    Moldt B; Miskey C; Staunstrup NH; Gogol-Döring A; Bak RO; Sharma N; Mátés L; Izsvák Z; Chen W; Ivics Z; Mikkelsen JG
    Mol Ther; 2011 Aug; 19(8):1499-510. PubMed ID: 21468003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Going non-viral: the Sleeping Beauty transposon system breaks on through to the clinical side.
    Hudecek M; Izsvák Z; Johnen S; Renner M; Thumann G; Ivics Z
    Crit Rev Biochem Mol Biol; 2017 Aug; 52(4):355-380. PubMed ID: 28402189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.